Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy
Abstract We report a 54‐year‐old man with treatment‐resistant depression (TRD) and hypothyroidism who responded to LT3/LT4 combination, rather than LT4 alone. He was able to discontinue all antidepressant medications eventually. Interestingly, the patient has a DIO2 polymorphism.
Main Authors: | Ziyan S. Ahmed, Rinsha P. V. Sherin, Tatiana L. Fonseca, Thanh D. Hoang, Mohamed K. M. Shakir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.5651 |
Similar Items
-
Investigating the Effect of Genetic Polymorphisms of Deiodinase Type 2 on Levothyroxine Dose Requirements in Patients with Hypothyroidism
by: Nada Hamid Rasheed, et al.
Published: (2023-08-01) -
Depression and hypothyroidism: Literature review and case report
by: P. Coucheiro Limeres, et al.
Published: (2021-04-01) -
P-glycoprotein polymorphism and levothyroxine bioavailability in hypothyroid patients
by: Ezgi Öztaş, et al.
Published: (2018-02-01) -
Levothyroxine supplementation among individuals with Subclinical Hypothyroidism and Depression | a review
by: M. Ribeiro, et al.
Published: (2022-06-01) -
Prevalence of anxiety and depressive symptoms among patients with hypothyroidism
by: Manish Bathla, et al.
Published: (2016-01-01)